[
  {
    "ts": null,
    "headline": "Why Bristol-Myers Squibb (BMY) Is Among the Best Long-Term Dividend Stocks to Invest in Right Now",
    "summary": "We recently compiled a list of the 12 Best Long-Term Dividend Stocks to Invest in Right Now. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other best dividend stocks for the long term. The allure of steady income remains a top priority, come rain […]",
    "url": "https://finnhub.io/api/news?id=cc6ba180f857fb117307ffcc1ee56f68e4d7571321f9c020145008f4bc417d64",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734034295,
      "headline": "Why Bristol-Myers Squibb (BMY) Is Among the Best Long-Term Dividend Stocks to Invest in Right Now",
      "id": 131952836,
      "image": "https://s.yimg.com/ny/api/res/1.2/ZsrqNB_sdV78LPtS9DZ12A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 12 Best Long-Term Dividend Stocks to Invest in Right Now. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other best dividend stocks for the long term. The allure of steady income remains a top priority, come rain […]",
      "url": "https://finnhub.io/api/news?id=cc6ba180f857fb117307ffcc1ee56f68e4d7571321f9c020145008f4bc417d64"
    }
  },
  {
    "ts": null,
    "headline": "CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal",
    "summary": "Candel stock rallies 68% on meeting the primary goal in a phase III study of CAN-2409 combo therapy compared to SOC radiation therapy for prostate cancer.",
    "url": "https://finnhub.io/api/news?id=cd23adf3dd9985ad2892692e3678e6857d585ba223815ba54d8c88e36400309d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734017460,
      "headline": "CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal",
      "id": 131932010,
      "image": "https://media.zenfs.com/en/zacks.com/675c0ae70cb5036ad2ceb9062f13afc2",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Candel stock rallies 68% on meeting the primary goal in a phase III study of CAN-2409 combo therapy compared to SOC radiation therapy for prostate cancer.",
      "url": "https://finnhub.io/api/news?id=cd23adf3dd9985ad2892692e3678e6857d585ba223815ba54d8c88e36400309d"
    }
  }
]